Introduction {#Sec1}
============

Electrical brain waves (or oscillations) can be used to define behavioral domains called vigilance (or behavioral) states. At any time, an animal appears to be in one of three 'global brain states', wakefulness, non-rapid-eye-movement (NREM) sleep (or slow-wave-sleep in rodents), and REM (or paradoxical) sleep, as assessed by the oscillatory profile measured in the electroencephalogram (EEG, or electrocorticogram (ECoG) in rodents). EEG signals provide information at a high-temporal resolution (10--100 ms) about an animal's arousal state, behavior, and prior sleep/wake history. Behavioral states were also found to delineate distinct physiological and molecular brain milieus, e.g.^[@CR1],[@CR2]^. Furthermore, increasing evidence suggests that oscillatory patterns are active functional determinants of brain circuits processing, and their behavioral outcomes, e.g.^[@CR3]--[@CR6]^.

State-specific oscillations emerge from dynamic neuronal activity in interconnected cortical and subcortical microcircuits responding to external stimuli and a multitude of internal indices of the animal's circadian, homeostatic, and motivational state. Many of these signals are implemented by a set of key neuromodulators (acetylcholine, histamine, noradrenaline \[NA\], serotonin, dopamine, and hypocretin-1 and 2/orexin-A and B \[HCRT\]), produced in a set of subcortical arousal 'hubs', that are active when the animal is awake, but mostly silent in NREM sleep. Although all these neuromodulator-producing neurons regulate waking states and attention, they widely differ in their neuroanatomical and electrophysiological properties, the contexts that activate them, and the downstream effectors they act upon, and their behavioral translation^[@CR7],[@CR8]^. The complex interplays between these neuromodulators are poorly understood.

HCRT and NA are produced by neurons residing in, respectively, the lateral hypothalamus and a set of pontomedullary NA nuclei^[@CR9]^, of which the locus coeruleus (LC) is the best characterized. Each cell group receives multiple inputs and broadcasts to many nuclei, including to each other^[@CR10]^. LC provides approximately half of all brain NA^[@CR11]^, and all the neocortical and hippocampal NA. LC cells fire tonically at a frequency that is behavioral state-dependent, and in waking tends to increase with arousal level^[@CR12]^. In response to salient stimuli, LC neurons shift to a 8--10 Hz phasic firing mode, which differentially regulates downstream circuit processing^[@CR13],[@CR14]^. NA release in targets therefore depends on the firing pattern of NA^LC^ cells, which is modulated by many afferents. One of the densest innervation originates from HCRT neurons^[@CR9],[@CR15]--[@CR17]^. HCRT cell activity is enhanced by a wide range of behaviorally relevant stimuli, and was demonstrated to drive HCRT release in the LC, and to increase NA^LC^ neuron firing rate, both in slices^[@CR16],[@CR18],[@CR19]^ and behaving animals^[@CR20]^. HCRT in the LC, in turn was shown to evoke NA release in the dentate gyrus^[@CR21]^, and the prefrontal cortex (PFC)^[@CR22],[@CR23]^. How much of the LC response to salient cues reflects a primary response of HCRT neurons to these cues, remains unclear.

HCRT acts by signaling through two G-protein-coupled receptors, HCRTR1 and HCRTR2^[@CR24]^, which are differentially expressed throughout the brain. *In situ* hybridization reveals that the LC, as well as the brainstem's six other NA cell groups, express *Hcrtr1*, in relative absence of *Hcrtr2* expression^[@CR20],[@CR25],[@CR26]^.

Optogenetic stimulation of both HCRT and NA^LC^ neurons increases the probability of sleep-to-wake transitions, but with much faster dynamics for NA^LC^, than HCRT neurons^[@CR27],[@CR28]^. NA^LC^ optogenetic inhibition concerted with HCRT cell stimulation represses, while co-stimulation enhances, awakening^[@CR29]^, establishing the HCRT-LC connection as a critical circuit to transition from sleep to wake. Loss of HCRT signaling by disruption of *Hcrt*, both *Hcrtr1* and *Hcrtr2* genes, or ablation of HCRT-producing cells, profoundly alters behavioral state regulation, and closely phenocopies narcolepsy symptomatology^[@CR30]--[@CR32]^. Loss of NA by disruption of the gene encoding the NA-synthesizing enzyme, *Dopamine*-*β*-*hydroxylase* (*Dbh*), produced contradicting reports, with indication of normal^[@CR33]^, or reduced^[@CR34]^ wakefulness in mice, and reduced wakefulness in zebrafish^[@CR35]^.

Here we use genetic tools to inactivate the functional connectivity between HCRT neurons and downstream NA neurons. We generated a novel CRE recombinase-dependent *Hcrtr1* KO mouse strain, and we used a *Dbh*-*Cre* transgene^[@CR36]^ to drive *Cre* expression in NA cells. In the resulting (*Hcrtr1*^*Dbh*-*CKO*^) mice, *Dbh*-expressing cells undergo Cre-mediated deletion of an essential *Hcrtr1* gene fragment, thus abolishing HCRTR1 signaling in all brain NA circuits. As HCRTR1 is thought to get transported to the NA cell membrane in the soma, the dendrites, and the axonal terminals, our mutant mice' NA neurons lose the ability to respond both postsynaptically to HCRT (whithin NA cell groups), and presynaptically (within target tissues). Indeed NA release is finely regulated at the level of NA terminals, not only by autoinhibitory α2-adrenoceptors, but also by dopamine and other presynaptic receptors^[@CR37],[@CR38]^. HCRTR1 was reported to act presynaptically at a variety of brain sites, regulating the release of glutamate, GABA or Ach^[@CR39]--[@CR47]^. Whether HCRTR1 acts presynaptically at NA terminals has, to our knowledge, not yet been investigated.

As HCRTR1 modulates behavioral arousal induced by both aversive and appetitive stimuli^[@CR8]^, we assessed the global impact of the loss of HCRT-to-NA signaling by measuring brain oscillatory dynamics of *Hcrtr1*^*Dbh*-*CKO*^ and control mice as they freely behaved in environments of both negative and positive emotional valence. Loss of HCRT-to-NA signaling was found to primarily affect the main ECoG correlates of arousal, i.e. θ and fast-γ frequencies. In stress-associated conditions, *Hcrtr1*^*Dbh*-*CKO*^ mice' waking exhibited increased δ and inter-δ/θ (4--7 Hz) activity, suggestive of reduced alertness, while normal induction of θ and fast-γ oscillations was blunted. Surprisingly, in spontaneous nocturnal nestbuilding-associated wake which precedes sleep, *Hcrtr1*^*Dbh*-*CKO*^ mice displayed higher θ and fast-γ activity. Our study evidences the role of HCRT-to-NA signaling in building an appropriate θ/fast--γ response in stressing environments, and reveals circumstances in which HCRT-to-NA signaling may serve to curb hyperarousal.

*An earlier version of this report was published on bioRxiv*^[@CR48]^.

Results {#Sec2}
=======

Generation of a Cre-dependent *Hcrtr1* KO mouse strain, and selective *Hcrtr1* gene inactivation in NA neurons {#Sec3}
--------------------------------------------------------------------------------------------------------------

We modified *Hcrtr1* in embryonic stem cells so that the gene gets fully inactivated in presence of CRE, but remains functional in its absence (Fig. [1a](#Fig1){ref-type="fig"}). We inserted two loxP sites to flank an essential N-terminal-encoding region, and further modified the *Hcrtr1* locus so that CRE-mediated loxP site-specific recombination has three main effects: (1) it excises exons 3 and 4, which encode the signal and N-terminal polypeptide up to within transmembrane domain 3 (a total of 126 aa), (2) it replaces the *Hcrtr1* open reading frame with a (promoterless) *Gfp* open reading frame, allowing to use GFP expression to monitor cells which have undergone *Hcrtr1* gene disruption, but have an active *Hcrtr1* promoter, and thus would normally express *Hcrtr1*, and (3) it inserts a polyadenylation signal downstream of the GFP cassette, and thus terminates transcription and precludes expression of downstream exons. This conditional KO (CKO, or 'floxed') allele is referred to as *Hcrtr1*^*flox*^.Figure 1Conditional inactivation of *Hcrtr1* in noradrenaline (NA) neurons: TH^+^ cells in the locus coeruleus of *Hcrtr1*^*Dbh*-*CKO*^ (CKO) mice express GFP in place of HCRTR1. (**a**) Schematic representation of homologous recombination between the *Hcrtr1* genomic locus and the targeting vector (TSS, transcription start site; filled rectangles depict protein-coding sequences, and unfilled rectangles represent untranslated regions). Two loxP sites (red triangles) were inserted to flank the first coding exon (exon 3) and exon 4, which together encode the N-terminal first 126 aa of HCRTR1. The neomycin resistance gene used for selection in embryonic stem cells (neo; flanked by two FRT sites shown as orange triangles) was deleted using the FLP recombinase, creating the *Hcrtr1*^*flox*^ allele. In *TgDbh*-*Cre*-expressing cells, CRE excises the inter-loxP fragment (1.1 kb), creating the *Hcrtr*~*1*~^+/*KO*-*Gfp*^ allele. In the latter, the translation start site (ATG) of *Hcrtr1* is replaced by the ATG of the *Gfp* cassette. Thus *Gfp* expression (green rectangle) becomes regulated by the *Hcrtr1* promoter. *Gfp* reading frame is followed by a polyadenylation site (pA) to terminate transcription and prevent downstream expression. (**b**--**f**) Representative confocal images of the locus coeruleus (LC) of mice of the indicated genotypes. Noradrenergic (NA) neurons are stained with a tyrosine hydroxylase antibody (TH^+^). Costaining with a CRE (**b**), GFP (**c**,**d**), or HCRTR1 (**e**,**f**) antibody is depicted. (**b**) shows that CRE is efficiently and specifically expressed in LC TH^+^ cells of a CKO mouse. (**c**) CKO mice express GFP in place of HCRTR1 in LC TH^+^ cells, while, in absence of CRE, (**d**) a CTR mouse lacks GFP immunoreactivity. (**f**) HCRTR1 immunoreactivity can be seen in LC TH^+^ cells of a CTR mouse, but not appreciably in LC TH^+^ cells of a CKO mouse (**e**). The CKO mouse exhibits however HCRTR1-immunoreactive, TH-negative cells outside the LC nucleus, consistently with NA cell-selective *Hcrtr1* gene disruption. The HCRTR1 antibody was raised against a peptide encoded by regions downstream of the CRE-mediated deletion. (**g**--**i**) Quantification of the percentage of TH^+^ neurons that are also immunoreactive for CRE (**g**), GFP (**h**), or HCRTR1 (**i**). Coronal sections collected at four levels throughout the LC were quantitatively assessed. Data are mean ± SEM values for (**g**,**h**) CKO (n = 3 for each), or (**i**) CKO (n = 3) and CTR (n = 4) mice. Boxed areas (and images to the right) represent fields delineated for cell counts (see Methods). The size indicated above scale bars in (**b**) applies also to (**c**--**f**). Mouse Genome Informatics: *Hcrtr1*^*flox*^ is *Hcrtr1*^*tm1*.*1Ava*^ (MGI:5637400), and *Hcrtr1*^*KO*-*Gfp*^ is *Hcrtr1*^*tm1*.*2Ava*^ (MGI: 5637401) ([www.informatics.jax.org/reference/j:226158](http://www.informatics.jax.org/reference/j:226158) ^[@CR50]^).

To generate NA-specific *Hcrtr1* deficient mice, *Hcrtr1*^*flox*/*flox*^ mice were crossed with mice harboring a *Dbh*-*Cre* BAC transgene^[@CR36]^. We established breeding pairs that generate two offspring groups: *Hcrtr1*^*flox*/*flox*^; *TgDbh*-*Cre*-positive (*Hcrtr1*^*Dbh*-*CKO*^, or CKO) mice, and *Hcrtr1*^*flox*/*flox*^; *TgDbh*-*Cre*-negative (*Hcrtr1*^*Dbh*-*CTR*^, or CTR) mice. All analyses rely on pair-wise comparison between these two groups.

To demonstrate that accurate Cre-dependent DNA recombination occurs at the *Hcrtr1* locus, we prepared tissue punches from various tissues and brain areas from CKO and CTR mice, and the *Hcrtr1* gene was analyzed and sequenced. Only genomic DNA from the LC area of CKO mice amplified diagnostic recombined fragments of the *Hcrtr1* gene, whose sequencing confirmed accurate genomic structure and inter-loxP deletion breakpoints (see Methods).

GFP labeling of NA^LC^ cells in *Hcrtr1*^*Dbh*-*CKO*^, but not *Hcrtr*~*1*~^*Dbh*-*CTR*^ mice, evidences *Hcrtr1*-to-*Gfp* open reading frame replacement {#Sec4}
---------------------------------------------------------------------------------------------------------------------------------------------------------

We first evaluated how efficient and specific the *Dbh*-*Cre* transgene used to target NA neurons was, by comparing tyrosine hydroxylase (TH) and CRE immunofluorescence in LC sections from CKO mice. Out of 732 TH-immunoreactive neurons, 689 expressed CRE (94.3 ± 2.1%, mean ± SEM for n = 3 mice; Fig. [1b,g](#Fig1){ref-type="fig"}). Conversely, 96.8 ± 1.4% of CRE-positive cells also expressed TH, confirming high penetrance and specificity of the transgene, respectively. Next, to determine efficiency and specificity of CRE-mediated recombination at the *Hcrtr1*^*flox*^ locus, LC sections were assayed for TH and GFP co-expression. This revealed bright GFP immunoreactivity in NA^LC^ cells of CKO mice (Fig. [1c](#Fig1){ref-type="fig"}), and its absence in CTR mice (Fig. [1d](#Fig1){ref-type="fig"}). Out of 674 TH-positive cells in LC of CKO mice, 658 co-expressed GFP (97.6 ± 1.3%, n = 3; Fig. [1h](#Fig1){ref-type="fig"}), hence had undergone CRE/loxP recombination, while among 710 GFP-positive cells, 92.9 ± 2.4% co-expressed TH, indicating, respectively, high penetrance and specificity of genomic deletion at the *Hcrtr1*^*flox*^ locus.

Loss of *HCRTR1* immunoreactivity {#Sec5}
---------------------------------

To further demonstrate that genomic deletion precludes HCRTR1 protein expression, we assessed LC sections of CKO and CTR mice for TH and HCRTR1 immunofluorescence (Fig. [1e,f,i](#Fig1){ref-type="fig"} and see Methods). Among 523 TH-positive cells in the LC of CTR mice, 498 were positive for HCRTR1 (93.3 ± 3.7%, mean ± SEM for n = 4 mice; Fig. [1f,i](#Fig1){ref-type="fig"}), while among 431 TH-positive cells in LC of CKO mice, only 11 were HCRTR1-positive (2.8 ± 2.0%, n = 3; Fig. [1e,i](#Fig1){ref-type="fig"}). Consistently with the NA-cell specificity of *Hcrtr1* disruption, HCRTR1-immunoreactive, TH-negative cells were present in brain areas outside the LC (Fig. [1e](#Fig1){ref-type="fig"}). These data demonstrate highly penetrant, Cre-dependent *Hcrtr1* KO in the LC TH^+^ neurons of our *CKO* mouse model.

To further validate our *Hcrtr1* mutagenesis strategy, we generated mice carrying the recombined (*KO*-*Gfp*) *Hcrtr1* allele (Fig. [1a](#Fig1){ref-type="fig"}) in all cells. To this end we crossed *Hcrtr1*^*flox*/*flox*^ animals to EIIa-Cre transgenic mice^[@CR49]^, a line expressing CRE in the pre-implantation embryo (see Methods). Early embryonic CRE/loxP recombination allowed transmission of the recombined *Hcrtr1* gene into the germ-line, creating a *Hcrtr1*^*KO*-*Gfp*^ mouse strain. Homozygosity of the mutation is expected to provide a *Hcrtr1* null. Furthermore, since *Gfp* is under control of the endogenous *Hcrtr1* promoter, heterozygous *Hcrtr1*^+/*KO*-*Gfp*^ animals permit mapping of *Hcrtr1* gene activity across the organism^[@CR50]^. As expected, nearly all TH^+^ cells in the LC of *Hcrtr1*^+/*KO*-*Gfp*^ mice express GFP (see Supplementary Fig. [S1a](#MOESM1){ref-type="media"}). Out of 709 TH-expressing cells (n = 3 mice), 99.6 ± 0.3% also expressed GFP, and 91.2 ± 4.6% of GFP-positive cells in the LC also expressed TH, confirming the robust activity of the *Hcrtr1* promoter in NA^LC^ cells.

We next analyzed HCRTR1 immunofluorescence in mice heterozygous (n = 3), or homozygous (n = 3) for the *Hcrtr1*^*KO*-*Gfp*^ mutation. LC imaging confirmed loss of HCRTR1 immunofluorescence in homozygous *Hcrtr1*^*KO*-*Gfp*/*KO*-*Gfp*^ mice (Fig. [S1b,c](#MOESM1){ref-type="media"}). In contrast to CKO mice, the latter mice have lost HCRTR1-immunoreactivity not only in LC TH^+^ cells, but in areas surrounding the LC as well (Fig. [S1c](#MOESM1){ref-type="media"}). These data support the specificity of the antibody used in Fig. [1e,f](#Fig1){ref-type="fig"} to assess CKO and CTR mice, and creation of a constitutive *Hcrtr1* KO (null) mouse model.

Increased δ oscillatory activity in wakefulness of *Hcrtr1*^*Dbh*-*CKO*^ mice {#Sec6}
-----------------------------------------------------------------------------

A cohort of CKO (n = 9) and CTR (n = 7) animals were submitted to several behavioral paradigms across a 9-day period (Fig. [2](#Fig2){ref-type="fig"}) as their ECoG/EMG signals were recorded. In undisturbed conditions (baseline), total time spent in wakefulness (W), slow-wave-sleep (SWS), or paradoxical sleep (PS), and their temporal dynamics over the 24-h day did not differ between the two genotypes (Figs [3a](#Fig3){ref-type="fig"}, [S2](#MOESM1){ref-type="media"}, [S6](#MOESM1){ref-type="media"}, and Supplementary Table [S1](#MOESM1){ref-type="media"}). To assess the finer architecture of sleep-wake states, we quantified the distribution of episode duration, both with respect to episode number as well as the percentage of total time in each state spent in episodes of various durations (Figs [S2](#MOESM1){ref-type="media"} and [S3](#MOESM1){ref-type="media"}). Sleep-wake architecture was very similar for the two genotypes with the exception of PS. For this state we observed a right shift of the distribution of percent time spent in PS across episode duration categories (Fig. [S2b](#MOESM1){ref-type="media"} *Right*; interaction for factors 'episode duration' and 'genotype' two-way ANOVA, *P* \< 0.002), with CKO mice spending most of PS in \~2-min bouts (64--128 s), while CTR mice spent most of PS in \~1-min bouts (32--64 s).Figure 2Experimental design. A cohort of *Hcrtr1*^*Dbh*-*CKO*^ (n = 9) and *Hcrtr1*^*Dbh*-*CTR*^ (n = 7) littermate mice were sequentially exposed to distinct behavioral paradigms, as their ECoG was recorded. Spontaneous waking ECoG activity was analyzed in the first two baseline (BL) days. Starting at light onset (ZT0) of day 3, mice were submitted to total sleep deprivation for 6 hours (6 h) in their home cage (EW or enforced waking). Mice were then left undisturbed for two days. At dark onset (ZT12) of day6, nest material was introduced (+Nestlet), and the waking ECoG analyzed in the following 24 h. After an additional two intervening days, 3 h after light onset (ZT3) of day 9, each mouse was removed from its nesting cage, and transferred to a fresh cage (cage change, CC). CC-induced waking was analyzed until the next SWS-onset. Shaded areas represent the 12 h dark phases.Figure 3Spontaneous vs. enforced wakefulness. (**a**) Mean (±SEM) hourly values of (*Top*) total waking time \[min/h\], (*Middle*) theta-dominated-waking (TDW) \[min/h\], and (*Bottom*) locomotor activity (LMA) \[counts/h\] across experimental days 1--3 in *Hcrtr1*^*Dbh*-*CKO*^ (CKO, black round symbols), and *Hcrtr1*^*Dbh*-*CTR*^ (CTR, grey round symbols) mice. ECoG spectra are shown for: (**b**) wakefulness in baseline dark phase ZT12--18, (**c**) TDW in baseline dark phase ZT12--18, and (**e**) enforced waking ZT0--6. ECoG power density is expressed as % of a baseline power reference value, calculated for each mouse across all states and all frequencies over 48 h^[@CR135]^ (see Methods) \[% of 'BL total power'\]. Note non-linear axes. Insets in (**b** and **e**) show ECoG spectra magnified across frequency ranges of interest, depicted with linear axes. Waking spectra of CKO mice differed significantly from those of CTR mice in all 3 cases (**b**,**c**,**e**). Spectra depicted in b and e demonstrate significant genotype, and genotype X frequency effects across 0.75--80 Hz (two-way ANOVA, *P* \< 0.001 for all). Baseline TDW (**c**) demonstrates a significant genotype effect (two-way ANOVA, *P* \< 0.001), with no genotype X frequency interaction (*P* = 0.249). CKO mice' baseline waking showed enrichment in frequencies in the δ range (1.25 to 2.75 Hz) relative to CTR littermates (**b**). During EW (**e**), CKO' ECoG power increase extended to encompass the 1.5--6.75 Hz (δ + inter-δ/θ), and 13.5--24 Hz (β) frequency ranges (post-hoc independent two-tailed student *t*-tests, *P* \< 0.05). Inset in e shows the theta rhythm's peak frequency (TPF) during EW in CKO (black round symbol), and CTR (grey round symbol) mice (mean ± SEM). TPF is slower in CKO mice (two-tailed t-test, *P* \< 0.05, red asterisk). (**f**) To extract the spectral traits specific to the EW response within each genotype, EW power spectra are expressed relative to baseline waking power spectra (as averaged across 48 h in recording days 1--2). EW/baseline power density ratio is expressed as log~2~ with 0 indicating no change and ±1.0 indicating a 2-fold change. CKO mice' EW-response is marked by a lesser increase in the θ range (bins concerned: 8.75--9.5 Hz) and a lesser decrease in the δ and inter-δ/θ ranges (bins concerned 1.75--3 Hz and 4.5--7 Hz). (**d**) Timecourses of waking δ (1--4 Hz), inter-δ/θ (4--7 Hz), and β (15--30 Hz) activity during days 1--3, expressed as % of the same baseline total ECoG power reference as used for the waking spectra in b-c and e. Red bars indicate significant genotype differences (post-hoc independent two-tailed student *t*-tests that followed two-way ANOVAs, *P* \< 0.05).

Furthermore, during the 18 h for which recovery sleep was monitored after the 6-h sleep deprivation, hourly sleep-wake state amounts did not differ between the two genotypes (Figs [3a](#Fig3){ref-type="fig"} and [S6](#MOESM1){ref-type="media"}), again with the exception of PS (Fig. [S2a](#MOESM1){ref-type="media"}). The timecourse of hourly values of PS time was significantly altered by genotype (interaction factors 'time' and 'genotype' two-way ANOVA, P = 0.01). CKO mice spent significantly more time in PS than did CTR mice in the middle of the recovery light period \[ZT8--10\], which is the period of maximal PS rebound for both genotypes. In that interval, CKO expressed a 26% increase in PS time over CTR mice (CKO: 14.4 ± 0.5 min vs CTR: 11.4 ± 0.4 min; t-test p = 0.0005), which was due to a 20-s lengthening of mean PS episode duration (+31%) (CKO: 84.7 ± 5.6 s vs CTR: 64.9 ± 4.1 s; t-test, P = 0.018), leaving episode number unaffected (−5%; t-test, p = 0.691). Altogether these data suggest that PS maintenance, but not initiation, is favoured in CKO mice. An increase in PS state stability in CKO mice may be related to the known PS-suppressing activity of the HCRT-1 peptide, as demonstrated when locally applied in LC of rats^[@CR20]^.

While the duration of CKO mice' baseline waking was unchanged, its spectral quality was. Spontaneous wakefulness of CKO mice showed increased ECoG activity within the δ frequency-range (1.25 to 2.75 Hz) relative to CTR littermates in the dark phase first 6 h (ZT12--18) (Fig. [3b](#Fig3){ref-type="fig"}). To delineate the times of day in which CKO mice' wake differs in spectral activity, the power dynamics of the waking ECoG in specific frequency bands were plotted across days 1--3 using the same power reference as used in the waking spectra of Fig. [3b](#Fig3){ref-type="fig"} (see Methods). This revealed that CKO mice' waking state is enriched in δ frequencies throughout recording days 1--3, but particularly at times of increased behavioral activity (i.e., in dark phase and during EW; Fig. [3d](#Fig3){ref-type="fig"} Bottom). It thus appears that at critical times of enhanced arousal, CKO mice are impaired in reducing δ activity as normal mice do. Heightened δ activity while awake is associated with drowsiness and increase sleep pressure in rodents and humans^[@CR51],[@CR52]^.

We then asked whether the enhanced waking δ activity of CKO mice could also be observed during active waking, or more specifically in the 'theta-dominated waking substate' (TDW), we previously formulated an ECoG-based algorithm to identify^[@CR53]^. We found that CKO mice' baseline TDW state features increased power in the δ range (2.0--3.0 Hz) relative to CTR mice as well (Fig. [3c](#Fig3){ref-type="fig"}). Further analysis revealed that increased δ power also affects CKO mice' non-TDW waking (akin to 'quiet waking', not shown). Therefore the weakened ability of CKO mice to downregulate δ oscillations across waking substates suggests they suffer a globally reduced level of alertness.

Enhanced infra-θ oscillatory activity, and impaired θ and fast-γ power induction in enforced wakefulness of *Hcrtr1*^*Dbh*-*CKO*^ mice {#Sec7}
--------------------------------------------------------------------------------------------------------------------------------------

At light onset (ZT0) of day 3, when sleep propensity is maximal, an experimenter entered the room, and the gentle handling sleep deprivation procedure was initiated and maintained for 6 h. CKO mice' ECoG spectra differed more extensively from CTR mice spectra in EW than they did in baseline waking (Fig. [3e](#Fig3){ref-type="fig"}). ECoG power across 1.5 to 6.75 Hz, encompassing δ and some of the traditionally defined θ range, and across 13.5 to 24 Hz (β) frequencies were enhanced in CKO mice. A prominent component of this activity increase occurs in the 4.0--7.0 Hz window, i.e., above the δ range but below the θ rhythm characteristic of explorative locomotion and voluntary behaviors in rodents^[@CR54]^. We refer to the 4.0--7.0 Hz range in mice as the 'inter-δ/θ' band (although it is sometimes included within the 'θ' window by others^[@CR55]^. We reserve 'θ' for the higher-frequency (7.5--11.5 Hz), narrow-bandwidth, hippocampal oscillations that are specifically induced upon active waking, and define the TDW state^[@CR53]^. In contrast, the 4.0--7.0 Hz activity (see peak in baseline waking ECoG spectra, Fig. [3b](#Fig3){ref-type="fig"}) dominates during quiet waking and automatic behaviors, and it increases as sleep homeostatic pressure rises^[@CR51],[@CR55]^.

Next, we examined the dynamics of the two other oscillatory ranges associated with reduced arousal (inter-δ/θ, and β) (Fig. [3d](#Fig3){ref-type="fig"}). Throughout the three days, CKO mice exhibited higher δ, but also inter-δ/θ, and, to a lesser degree, β (15--30 Hz) activity, compared to CTRs. Interestingly, CKO mice exhibited a steep power increase in all three bands in the course of EW, while this was not the case in control mice. This again indicates that CKO mice have an impaired ability to repress infra-θ oscillations at times of enhanced arousal, and furthermore suggests a faster build up rate of electrocortical signs of sleep pressure.

In both CKO and CTR mice, EW is singularized from average baseline waking by emergence of a sharp θ rhythm (Figs [3e](#Fig3){ref-type="fig"} and [4a](#Fig4){ref-type="fig"}). EW in CKO mice however differed from CTR mice' EW in θ frequency and power. In CKO mice, the θ rhythm was significantly slower (Fig. [3e](#Fig3){ref-type="fig"} inset; CKO vs. CTR, 8.1 ± 0.1 Hz vs. 8.6 ± 0.1 Hz; *t*-test; t~14~ = −3.749; *P* = 0.0022; and see Supplementary Table [S2](#MOESM1){ref-type="media"}). To extract the spectral features of each genotype's EW-response, EW spectra were contrasted to baseline waking spectra (Fig. [3f](#Fig3){ref-type="fig"}). This revealed that the increased θ, and decreased inter-δ/θ activity, that characterize the CTR mice' response during the gentle-handling procedure, were significantly diminished in CKO mice. Lower activity in the θ range, but higher infra-θ (δ and inter-δ/θ) activity mark the blunted EW θ response of CKO mice, and both are suggestive of a weaker medial septal/hippocampal activation^[@CR56]^.Figure 4*Hcrtr1*^*Dbh*-*CKO*^ mice exhibit weakened θ and fast-γ activity responses during gentle handling-enforced wakefulness (EW). (**a**) Heatmap depicting the ECoG spectral dynamics of the waking state across days 1--3. ECoG power in each 0.25 Hz frequency bin is expressed as % of its average value in the last 4 h of the light phase (ZT8--12) in baseline days 1--2. Values are color-coded according to the scale shown on the right. (**b**) Differential dynamics of the waking ECoG of CKO and CTR mice (CKO-CTR). Spectral dynamics shown in (**a**) were substracted from each other \[Δ%\]. While both CKO and CTR mice' waking state exhibit sharp increases in θ and fast-γ activity during EW (a), CKO mice' waking exhibits a markedly lower θ, as well as fast-γ power, relative to CTR mice during EW, in particular in the first hour (dark blue), and a concomitant increase in infra-θ power. Episodes in which CKO-CTR differential activity shows, inversely, higher θ and fast-γ, power in CKO, occur during spontaneous waking, in particular in the dark phase, at times of high wakefulness (see Fig. [3a](#Fig3){ref-type="fig"}), during both baseline and recovery night. Such particularly pronounced episodes appear to occur during the recovery night after EW. White lines delimit areas in which power density significantly differs between genotypes (two-tailed t-tests, *P* = 0.05). Note that color scales in (**a** and **b**) differ. (**c**) Timecourses of the waking ECoG activity in the δ (1--4 Hz) and inter-δ/θ (4--7 Hz) frequency bands across 6-h of EW, are depicted, with power expressed, as in (**a**), as % of its mean value in baseline ZT8--12 wakefulness.

Robust θ oscillations and TDW expression characterize vigorous explorative locomotor activity (LMA), but can also uncouple from it^[@CR53]^, and be observed in immobile rats following a running bout^[@CR57]^, or in association with motivational activation^[@CR58]^. To investigate this relation in our mutant, LMA was monitored. While LMA was normal throughout the two baseline days, its increase during the 6-h EW period was markedly reduced in CKO mice (Fig. [3a](#Fig3){ref-type="fig"} Bottom; CKO vs. CTR, 929 ± 120 vs. 1631 ± 190 counts; Mann-Whitney U test, *P* = 0.01). We previously found that mice lacking all HCRT signalling (*Hcrt*^*ko*/*ko*^) exhibit reduced locomotion relative to WT littermates throughout baseline and EW^[@CR53]^, with a reduction during EW that was very similar in extent to the one we observe here in CKO mice relative to their CTR littermates. This suggests that the role of HCRT in locomotion relies primarily on the HCRT-to-NA pathway in EW, but on other HCRT targets in spontaneous waking.

To investigate more globally the spectral dynamics of wakefulness, an ECoG power heatmap was generated as a function of frequency and time, across the entire 0.75--90 Hz spectral range, and days 1--3 (Fig. [4a](#Fig4){ref-type="fig"}). As waking spectra show a strong dependence on prior sleep/wake history and homeostatic sleep pressure, the waking ECoG was referenced to baseline light phase last 4 h, i.e., after the major sleep period, when sleep pressure has returned to trough values (see Methods, Fig. [4](#Fig4){ref-type="fig"} legend, and Fig. [S4](#MOESM1){ref-type="media"}). This analysis revealed in both CKO and CTR mice powerful θ and fast-γ activity surges occurring in concert during EW, as well as, but to a lesser degree, in baseline waking of the first half of the dark period (Fig. [4a](#Fig4){ref-type="fig"}).

To next specifically delineate the genotype-based differences in this response, the two spectral dynamics obtained in Fig. [4a](#Fig4){ref-type="fig"} were subtracted from each other to produce the CKO-CTR differential profile in waking ECoG dynamics shown in Fig. [4b](#Fig4){ref-type="fig"}. This reveals a number of genotype differences. *CKO* mice feature a prominent deficit in enhancing θ oscillations during EW (blue color-code in b). θ oscillatory power induction, bandwidth narrowing, and frequency increase that characterized CTR EW are all weakened in CKO mice. Furthermore, a 70--90 Hz activity, closely paralleling θ power dynamics, was found to surge during EW, and to be similarly weakened in CKO mice. This is in line with the reduced θ power response of CKO mice in EW, as observed by spectral analysis in Fig. [3f](#Fig3){ref-type="fig"}. Surprisingly, some time intervals in the active (dark) phase, conversely, appeared to be associated with enhanced θ activity in CKO relative to CTR mice (Fig. [4b](#Fig4){ref-type="fig"}), a finding further replicated, and extensively discussed, below. Analysis of the dynamics of δ (1--4 Hz) and inter-δ/θ band (4--7 Hz) oscillatory power throughout EW 6-h revealed enhanced δ, and inter-δ/θ activity in CKO mice, in particular in EW' 2nd half (Fig. [4c](#Fig4){ref-type="fig"}), a finding consistent with EW spectral profiles (Fig. [3e,f](#Fig3){ref-type="fig"}). Altogether our data suggest that the hippocampal θ and fast-γ oscillatory responses to EW are blunted in CKO mice. Hence we propose that HCRTR1-dependent neuromodulation of NA microcircuits contribute significantly to these responses.

*Hcrtr1*^*Dbh*-*CKO*^ mice exhibit weakened θ and fast-γ oscillatory responses to cage change {#Sec8}
---------------------------------------------------------------------------------------------

Following EW and recovery period, mice were left undisturbed for 2 days. At dark onset of day6, each mouse was provided nesting material, and left undisturbed for another 2 days (see next section). To assay capacity to adapt to a new environment, mice were transferred from their nesting home cage to a clean cage at ZT3 (see Fig. [2](#Fig2){ref-type="fig"}), a time ordinarily spent predominantly asleep (Fig. [S6](#MOESM1){ref-type="media"}). Cage change (CC) had a powerful arousing effect lasting between 1.5--2 h in both genotypes, (Fig. [5a](#Fig5){ref-type="fig"} *Top*). The ECoG response to CC however differed between the two groups (Fig. [5c](#Fig5){ref-type="fig"}). An active waking-like θ activity peak emerges in both mouse groups, but it appears blunted in CKO mice.Figure 5*Hcrtr1*^*Dbh*-*CKO*^ (CKO) mice display weakened θ and fast-γ oscillatory responses upon transfer from their nesting cage to a clean cage. Mice were transferred to a fresh cage at ZT3 of the 9^th^ recording day. (**a**) Mean (±SEM) hourly values of (*Top*) total waking time \[min/h\], (*Middle*) theta-dominated-waking (TDW) \[min/h\], and (*Bottom*) locomotor activity (LMA) \[counts/h\] in the day preceding, and the day in which cage change (CC) occurred in CKO and CTR mice. (**b**) Latencies to SWS-onset are calculated as the time between CC and the first SWS episode \[minute\]. (**c**) Waking ECoG spectra from CC to SWS-onset in *Hcrtr1*^*Dbh*-*CKO*^ (CKO, n = 8), and *Hcrtr1*^*Dbh*-*CTR*^ (CTR, n = 6) mice, with power density values, expressed as % of each animal's baseline ECoG 'total power' reference, as for spectra shown in Fig. [3b,c,e](#Fig3){ref-type="fig"}. Note the non-linear axes. CC-induced waking spectra of CKO and CTR mice differed, demonstrating significant genotype, and genotype X frequency effects across 0.75--80 Hz (two-way ANOVA, *P* \< 0.001 for all). CC induces a θ oscillatory peak in both genotypes, but its shape appears blunted in CKO mice. (**d**) To next extract CKO and CTR mice' CC-induced changes in spectral oscillatory activity, CC-induced power spectra (as shown in c) were expressed relative to the mice' baseline waking spectra (as averaged across the preceding 24 h period) (CC-induced/Baseline waking). Power density ratio is expressed as log~2~. CKO mice exhibit a lesser decrease in inter-δ/θ band activity, and a profoundly diminished 53--80 Hz (fast-γ) response compared to controls (two way ANOVA indicated significant genotype and genotype X frequency effects, *P* \< 0.001 for both). Red bars indicate significant genotype differences (post-hoc independent two-tailed *t*-test). (**e**) Spectral dynamics of the waking ECoG after cage change, across time (from ZT3 to SWS-onset), frequencies (0.75--90.0 Hz), and power (expressed as % of each mouse' mean waking ECoG power in that frequency bin in the preceding day's ZT8--12 time interval; color-coded as shown on the right. x-axis shows ZT time, adjusted to individual waking latencies to SWS-onset. (**f**) The differential CKO-CTR waking power dynamics following CC are depicted as they were for EW (Fig. [4b](#Fig4){ref-type="fig"}). Note that color codes for (**e** and **f**) differ. (**g**) Timecourses of ECoG power in two infra-θ frequency bands (1--4 Hz; 4--7 Hz) that were seen to respond in CC-induced waking in (**e**,**f**). ECoG power is expressed relative to the power in that band in average preceding day wakefulness. Red squares indicate time intervals in which ECoG power significantly differed between CKO and CTR mice (independent two-tailed student *t*-test, *P* \< 0.05).

When waking spectra were analyzed specifically for their CC-induced features, (by plotting power spectral density values following CC relative to each group's own average baseline values (Fig. [5d](#Fig5){ref-type="fig"}), and CC responses were contrasted between the two genotypes, CKO mice were seen to exhibit (i) a lesser CC-induced reduction in inter-δ/θ activity, similar to what was observed in EW (Fig. [3f](#Fig3){ref-type="fig"}), and (ii) a profoundly diminished fast-γ response across 55 to 80 Hz.

Heatmap representations of the spectral dynamics of the waking state expressed from CC to the subsequent SWS-onset (Fig. [5e](#Fig5){ref-type="fig"}), and the differential CKO-CTR dynamics thereof (Fig. [5f](#Fig5){ref-type="fig"}), confirm the weakened ECoG response of CKO mice. They powerfully illustrate CKO mice' blunted θ rhythm response, compared to CTR mice' response, as well as CKO mice' impaired inter-δ/θ band activity dampening relative to its value in preceding light phase last 4 h (Fig. [5e](#Fig5){ref-type="fig"} left, and [5f](#Fig5){ref-type="fig"}), while this CC-induced dampening is evident in controls (Fig. [5e](#Fig5){ref-type="fig"} right). CKO mice' weakened fast-γ response is also clearly apparent (Fig. [5e,f](#Fig5){ref-type="fig"}).

Analysis of the dynamics of δ (1--4 Hz) and inter-δ/θ band (4--7 Hz) oscillatory power in CC-induced waking (Fig. [5g](#Fig5){ref-type="fig"}) revealed a rise in inter-δ/θ activity in both genotypes as time progresses. This increase was steeper however in CKOs, in particular in the 2^nd^ hour (independent two-tailed student's *t*-test, *P* \< 0.05). In sum, although CC enhances θ synchrony and fast-γ oscillatory power in both CKO and CTR mice, weakening of both processes in CKO mice suggests HCRT-dependent noradrenergic activation participates in enhancing θ/fast-γ network activity in response to adverse environmental changes.

Inverse θ and fast-γ dynamics of *Hcrtr1*^*Dbh*-*CKO*^ mice in nesting-associated waking compared to enforced, or CC-induced, waking {#Sec9}
------------------------------------------------------------------------------------------------------------------------------------

To next explore our mice' response to a novel, but unthreatening behavioral context, animals were recorded in a nestbuilding paradigm. Nesting material is rewarding in laboratory mice, and induces nestbuilding, a remarkably robust behavior^[@CR59],[@CR60]^. A square of shreddable compressed cotton adapted for mouse nestbuilding (Nestlet^TM^), which the mice had never experienced before, was introduced in the homecage at dark onset (ZT12) of day 6 (see Fig. [2](#Fig2){ref-type="fig"}). Nestlet-to-nest conversion was confirmed at next light onset in all animals (CKO n = 5; CTR n = 5) (see Methods).

Video-based behavioral analysis of a subset of mice (CKO n = 3; CTR n = 1) evidenced two major nest material interactive periods during the night: an early-night 'discovery phase', with numerous, brief episodes in which mice explored/shortly manipulated the Nestlet, and a late-night phase with longer manipulating bouts, and sustained nestbuilding (Fig. [S5](#MOESM1){ref-type="media"}). Late-night bouts typically preceded SWS episodes. CKO mice spent more time awake than CTR mice in the time interval immediately preceding light onset (Fig. [6a](#Fig6){ref-type="fig"}).Figure 6Availability of nesting material induces a stronger θ and fast-γ oscillatory response in *Hcrtr1*^*Dbh*-*CKO*^ (CKO) mice than it does in control littermates in late night wakefulness that precedes sleep. Nest material (a Nestlet^TM^) was provided at dark onset (ZT12), and the ECoG was recorded in the following 24 h. (**a**) Mean (±SEM) hourly values of (*Top*) total waking time \[min/h\], (*Middle*) theta-dominated-waking (TDW) \[min/h\], and (*Bottom*) locomotor activity (LMA) \[counts/h\] across the night that followed Nestlet addition, and the following light phase. Red asterisks denote time intervals with significant genotype differences (*t*-test, *P* \< 0.05) (**b**) ECoG power heatmaps depict the spectral dynamics of the waking state across the nesting night and the following light phase as shown in Fig. [4a](#Fig4){ref-type="fig"}. Plotted are ECoG power densities for each 0.25 Hz frequency bin relative to their values in baseline wakefulness across the ZT8--12 period \[%\]. (**c**) Differential CKO-CTR heatmap of the nesting 24 h period was constructed similarly to Fig. [4b](#Fig4){ref-type="fig"}. Note that the color code for (**e** and **g**) differ. (**d**) Waking ECoG spectra in the last 2 h (ZT22--24) of the nesting night are plotted as % of the baseline total power reference \[%\], as in Fig. [3b,c,e](#Fig3){ref-type="fig"}. CKO and CTR mice' spectra demonstrate significant genotype, and genotype X frequency effects across 0.75--80 Hz (two-way ANOVA, *P* \< 0.001 for all). (**e**) ZT22--24 waking spectra shown in (**d**) are contrasted to waking spectra at the same time of day in baseline. The resulting Nesting/Baseline waking ECoG power density ratio demonstrates a significant genotype effect (two-way ANOVA, *P* \< 0.001), but no genotype X frequency interaction (*P* = 1). Red bars indicate significant genotype differences (post-hoc independent two-tailed student *t*-test, *P* \< 0.05).

The spectral dynamics of the waking state in the 24 h following Nestlet addition were first globally assessed in ECoG power heatmaps (Fig. [6b,c](#Fig6){ref-type="fig"}). This corroborated the existence of two nocturnal phases of heightened arousal, and, surprisingly, suggested that CKOs express a waking state higher in θ and fast-γ activity than do CTR littermates in early night (ZT12--15), when Nestlet novelty is maximal, and again in the last 2 h of the night (ZT22--24), preceding sleep.

Because only the late-night phase was associated with sustained nestbuilding activity, we focused our spectral analysis on waking of the night's last 2 h (ZT22--24, Fig. [6d,e](#Fig6){ref-type="fig"}). To extract the electrocortical features specifically set in place in response to the nesting condition, we contrasted the ECoG power density values in waking during ZT22--24 of the nesting night to those in baseline waking in the same circadian time window. This confirmed that, conversely to EW and CC-induced waking, CKO mice' wakefulness in late-night exhibit enhanced θ, as well as enhanced fast-γ (50--80 Hz) activity, compared to CTR mice (compare Figs [3f](#Fig3){ref-type="fig"} to [5d](#Fig5){ref-type="fig"} and [6e](#Fig6){ref-type="fig"}). Enhanced θ and fast-γ power in late-night furthermore coincides with a higher waking content (min/h) relative to CTR mice (Fig. [6a](#Fig6){ref-type="fig"}), that video data suggest may be related to nestbuilding activity.

Nestbuilding-associated waking of CKO mice exhibited moreover enhanced β (15--30 Hz) relative to CTR mice (Fig. [6e](#Fig6){ref-type="fig"}), as had been observed in CKO mice' EW (Fig. [3f](#Fig3){ref-type="fig"}), and enhanced slow-γ (30.25--40.75 Hz) power (Fig. [6c,e](#Fig6){ref-type="fig"}). Elevated β and slow-γ synchrony are observed in dopamine-depleted rodents, and Parkinson disease (PD) patients in correlations with movement disorders^[@CR61],[@CR62]^.

Because enhanced locomotion is part of the active waking response, it was also examined in this nesting paradigm. Surprisingly, CKO mice' enhanced θ and fast-γ oscillatory responses were not matched by enhanced LMA. CKOs exhibited diminished LMA compared to CTRs, in early and late night (Fig. [6a](#Fig6){ref-type="fig"}), possibly reflecting stationary position assumed for Nestlet exploration/nestbuilding.

In summary, two paradigms of enhanced arousal under stress (EW and CC), and one ethologically-relevant, rewarding behavioral context (presence of nesting material prior to sleep), are found to elicit altered waking electrocortical responses in CKO mice relative to CTR mice, with, respectively, diminished, or enhanced θ and fast-γ activity. Figure [7](#Fig7){ref-type="fig"} summarizes quantitatively these differential dynamics in waking θ and fast-γ oscillations. Because we here address the behavioral context-dependence of the dynamics of waking spectra, ECoG power is expressed relative to the average baseline (ZT0--24) waking ECoG activity in each frequency band. Nocturnal nesting-associated activity, and diurnal threat-avoidance (during 'gentle handling'), or anxiety-related exploration (after CC^[@CR63]^ appear therefore to induce highly divergent modes of HCRT-to-NA circuit processing and network oscillatory activity. Our data moreover suggest that these divergent oscillatory modes may alternate in the course of a day. CKO mice exhibit, as mentioned earlier, spontaneous periods of θ and fast-γ-enriched wakefulness in baseline dark phase, and, in a particularly pronounced manner, during the recovery night that follows EW (Fig. [4b](#Fig4){ref-type="fig"}).Figure 7Bidirectional and context-dependent θ and fast-γ oscillatory responses of *Hcrtr1*^*Dbh*-*CKO*^ (CKO) and *Hcrtr1*^*Dbh*-*CTR*^ (CTR) mice in three paradigms of enhanced arousal, in adverse (EW, CC), or rewarding (NEST) environments. (**a**) Waking ECoG θ (7.5--11.5 Hz; *Left*), or fast-γ (55--80 Hz; *Right*) power is plotted across time in three behavioral paradigms: 6-h EW (ZT0--6; Top), from cage change (CC at ZT3) to sleep onset (*Middle*), or in the night following provision of a Nestlet at dark onset (ZT12; *Bottom*). Because we address the context-dependence of θ and fast-γ dynamics, ECoG power in each band is expressed as % of its average value in baseline waking (ZT0--24). For each time-interval, power values are calculated 0.25 Hz-frequency bin by 0.25 Hz-frequency bin (as in heatmaps of Figs [4](#Fig4){ref-type="fig"}--[6](#Fig6){ref-type="fig"}), and then averaged across the respective frequency ranges. An equal number of artefact-free 4-s waking epochs contributed to each time-interval for each mouse. The following intervals are plotted: EW, 10 intervals spanning 6 h; CC, 10 intervals spanning \~2 h; Nest, 18 intervals spanning 24 h (the first 13 are depicted). For each paradigm, two-way ANOVA for factors genotype and time revealed that θ power varies significantly with the animal's genotype (EW and CC: *P* \< 0.0001; Nest: *P* = 0.0025), and across time (*P* = 0.0001). While all time-intervals show the same θ power trend in a particular paradigm, significant genotype difference is found for two intervals (red squares, t-test *P* \< 0.05). Two-way ANOVA also indicates a significant genotype effect on fast-γ power for CC (*P* \< 0.0001), and Nest (P \< 0.035), and a significant time effect on fast-γ power in all 3 conditions (*P* \< 0.0001). Note how the dynamics of θ and fast-γ oscillatory activities evolve in concert. (**b**) Waking θ and fast-γ power responses in the two time intervals marked by red squares in (**a**) are plotted in the three behavioral paradigms as % of their respective mean power in baseline ZT0--24 waking. (Left) ECoG θ power varies significantly with genotype (*P* = 0.0129), and condition (*P* \< 0.0001), and shows a significant genotype X condition interaction (*P* \< 0.0003, two-way ANOVA). CKO mice exhibit a significantly lower θ oscillatory response relative to CTR mice in wake during EW and after CC, but a significantly higher θ oscillatory response following Nestlet addition (*t*-test *P* \< 0.05, indicated by red asterisks). (Right) ECoG fast-γ power tends to vary with genotype (*P* = 0.0507), and varies significantly with condition (P \< 0.0001), and shows a significant genotype X condition interaction (*P* = 0.0091, two-way ANOVA). t-test indicates that CKO mice display a significantly reduced fast-γ power response after CC (*P* \< 0.05).

SWS following threat-associated arousal is selectively deficient in slow-δ frequencies in *Hcrtr1*^*Dbh*-*CKO*^ mice {#Sec10}
--------------------------------------------------------------------------------------------------------------------

SWS quality critically depends on preceding wakefulness quality, in particular on time spent in θ-- and fast-γ-rich wake (TDW)^[@CR53]^. We previously showed that SWS δ power, a widely used marker of sleep homeostatic pressure, which is classically modeled as a function of prior sleep/wake history and increases with time spent awake^[@CR64],[@CR65]^, fails to reflect prior time awake in *Hcrt*^*ko*/*ko*^ mice in baseline. We found that this is linked to the fact that, while they spend a normal time awake, *Hcrt*^*ko*/*ko*^ mice' time in TDW state is profoundly diminished relative to WT littermates, due to a reduced ability to sustain TDW for a prolonged time^[@CR53]^. We further found that SWS following spontaneous waking is not only reduced in δ power in *Hcrt*^*ko*/*ko*^ mice, but also spectrally skewed, with a much more pronounced deficit in the slow-δ (δ1, 0.75--2.25 Hz) oscillatory component, than in the fast-δ (δ2, 2.50--4.25 Hz) range. The significance of distinct δ frequency ranges in SWS remains unclear, however a correlation between SWS δ1 component and prior active wake and related potentiation events was reported in other studies as well^[@CR66]^.

Unlike *Hcrt*^*ko*/*ko*^ mice, *Hcrtr1*^*Dbh*-*CKO*^ mice spend a normal time in TDW in baseline. However their waking ECoG during EW and after CC is diminished in θ and fast-γ activity relative to controls. Thus we hypothesized that subsequent SWS may also be affected, and spectrally differ from controls. Hence we analyzed SWS of *CKO* and *CTR* mice in baseline and following the 3 behavioral paradigms they were exposed to. To best capture the entire range of the sleep homeostatic response before it dissipates^[@CR65]^, we restricted our analysis on the first 20 min of SWS following: baseline light onset (Fig. [8a](#Fig8){ref-type="fig"}), EW (Fig. [8b](#Fig8){ref-type="fig"}), and CC (Fig. [8c](#Fig8){ref-type="fig"}), and differentially examined δ1 and δ2 activity. This revealed that CKO mice exhibit a severe δ1 power deficit in SWS following EW (Fig. [8b](#Fig8){ref-type="fig"}), and after CC (Fig. [8c](#Fig8){ref-type="fig"}), while δ2 power remains essentially normal. Baseline SWS (Fig. [8a](#Fig8){ref-type="fig"}) in contrast did not show a significance δ1 power deficit. CKO mice' SWS after EW and the nesting night was moreover enriched in β and slow-γ activity (Fig. [8b,d](#Fig8){ref-type="fig"}).Figure 8Slow-wave-sleep of *Hcrtr1*^*Dbh*-*CKO*^ mice is deficient in slow-δ (δ1) oscillations following exposure to stressful stimuli. SWS ECoG spectra across 0.75--40.0 Hz are shown for the first 20 min of SWS (**a**) after light onset in baseline, (**b**) after EW, (**c**) after CC-induced waking, and (**d**) after light onset following the night in which nest material was provided. ECoG power is expressed as % of the same baseline reference as used for waking spectra of Figs [3b,c,e](#Fig3){ref-type="fig"}, [5c](#Fig5){ref-type="fig"} and [6d](#Fig6){ref-type="fig"}. Vertical guides delineate the two δ oscillatory subranges (δ1, 0.75--2.25 Hz; δ2, 2.50--4.25 Hz). SWS spectra of CKO mice differed significantly from those of CTR mice in all 4 conditions (**a**--**d**). Spectra depicted in a-c demonstrate significant genotype, and genotype X frequency effects across 0.75--40 Hz (two-way ANOVA, *P* \< 0.02 for all). SWS after nestbuilding (**d**) demonstrates a significant genotype X frequency interaction effect (two-way ANOVA, *P* = 0.015), while factor genotype did not reach significance (P = 0.82). In the δ range, only SWS following EW and CC (**b**,**c**) exhibited significant differences in CKO mice (post-hoc t-test, *P* \< 0.05), with in both cases a more profound deficit in δ1 power. No significant deficit in δ1 power in SWS following nestbuilding, or in baseline, were found. (**e**) Average SWS δ1 and δ2 activity in the 20 min intervals analyzed in (**a**--**d**) indicate that SWS δ1 activity is diminished only after EW and CC in CKO relative to CTR mice (red asterisks, t-tests, *P* \< 0.05).

If CKO mice' SWS δ1 deficit after stressful arousal is linked, in full or in part, to the θ and fast-γ power paucity of their preceding wake, through mechanisms similar to those operating in *Hcrt*^*ko*/*ko*^ mice' baseline SWS, CKO mice' SWS after nestbuilding-associated waking, which conversely exhibits enhanced θ and fast-γ power, would not be expected to show an altered spectral distribution with underrepresented δ1 frequencies. CKO mice' SWS following the nesting night was found to lack any δ, or selective δ1, power deficit (Fig. [8d](#Fig8){ref-type="fig"}), in accordance with our hypothesis.

Dynamic analysis of the two SWS δ oscillatory ranges across days 1--3 (Fig. [S6c](#MOESM1){ref-type="media"}), and 8--9 (Fig. [S6d](#MOESM1){ref-type="media"}) revealed δ1 to be diminished in CKO mice at all times, but more profoundly so following periods of maximal arousal (EW, and CC; Fig. [S6c,d](#MOESM1){ref-type="media"} *Top*). Altogether, our data suggest that (1) the HCRT-to-NA circuit is critical to mount normal θ and fast-γ responses to environmental contingencies, (2) the content in θ and fast-γ frequencies of the waking ECoG affects not only subsequent SWS δ power, but also its spectral distribution, (3) waking enriched in θ and fast-γ frequencies induces preferentially a low-frequency component of δ oscillations in subsequent SWS.

Discussion {#Sec11}
==========

The main finding of this study is that chronic inactivation of HCRT-to-NA cell signaling affects θ and fast-γ frequencies during waking, and their repercussions on subsequent slow-δ frequencies during SWS. θ and fast-γ oscillations are electrocortical markers of active wakefulness and motivated behaviors. These rhythms provide a temporal framework on which the timing of neuronal spikes can be measured and computed during execution of complex behaviors such as navigation^[@CR67]^. The induction of these two markers of arousal were diminished in CKO mice relative to control littermates during EW and following CC, whereas the opposite was observed in nesting-associated wakefulness preceding sleep.

Scope of the *Hcrtr1*^*Dbh*-*CKO*^ mouse model {#Sec12}
----------------------------------------------

In CKO mice, NA neurons lack HCRTR1 in their soma, dendrites, as well as synaptic boutons. HCRT induces depolarization and increased firing rate of NA^LC^ cells^[@CR16],[@CR18],[@CR20]^, suggesting that HCRTR1 is present on NA^LC^ cell bodies or proximal dendrites, in agreement with the intense *Hcrtr1 in situ* signal over the LC^[@CR26]^. The present study confirms at cellular resolution that the *Hcrtr1* gene promoter is active in NA^LC^ neurons, as intense GFP-immunofluorescence was present in 98% of LC TH^+^ cells of CKO mice. HCRT receptors can enhance neurotransmitter release through either postsynaptic, or presynaptic effects^[@CR41]--[@CR46],[@CR68]^, and CKO mice are expected to be deficient in HCRTR1 expression and signaling not only in the NA cell nuclei, but also in their target tissues, such as the hippocampus, PFC, amygdala, ventral tegmental area (VTA), and the olfactory bulb^[@CR10],[@CR17]^. However, activity of HCRTR1 at the level of NA cell axon terminal membranes has, to our knowledge, not yet been formally described.

The downstream effectors of HCRTR1 are known to be multiple and context-dependent. HCRTR1 can act through a great variety of signaling cascades, to mediate short-term changes in ionic conductances, or long-term changes in neuronal circuitry^[@CR24]^. As HCRT enhances NA^LC^ cell firing, we interpret CKO mice' phenotype at first approximation as the result of widespread loss in HCRT-induced NA signalling. HCRTR1 deficiency may however alter many other functions of NA neurons, such as signalling through other receptors, release of other neurotransmitters^[@CR69]^, synaptic plasticity^[@CR70]^, or gene expression, all of which contributing to the global phenotype. Further electrophysiological and molecular analyses of our mice are needed to evaluate these effects.

Slowing of the oscillatory profile of wakefulness {#Sec13}
-------------------------------------------------

Total time spent awake was normal in CKO mice in baseline conditions. Thus, although awakening induced by optogenetic stimulation of HCRT neurons was shown to be blocked by the concomitant photoinhibition of NA^LC^ cells^[@CR29]^, loss of HCRTR1 in NA cells of CKO mice did not diminish total baseline waking, bout number or duration. This discrepancy may have several causes. First, whereas optogenetic manipulations acutely modulate neuronal activity, NA cells of CKO mice are thought to lose *Hcrtr1* gene function at the time the *Dbh*-*Cre* transgene is first expressed, i.e. in mid-gestation^[@CR36]^. Compensatory mechanisms set in place during development^[@CR71]^ may partially rescue CKO mice' wake by upregulating other arousal pathways. For instance, increases in histamine cell number were reported in both narcoleptic patients and mouse models^[@CR72]^. To examine whether NA^LC^ cell-specific *Hcrtr1* gene inactivation at an adult stage causes a more severe phenotype than the one we report in CKO mice, a *Th*-driven *Cre*-expressing viral vector may be injected in the LC of adult *Hcrtr1*^*flox*/*flox*^ mice. Second, although under optogenetic settings the HCRT-to-NA^LC^ circuit critically mediates awakening, under physiological conditions, other HCRT targets may also elicit state transitions, and the HCRT-to-NA^LC^ circuit may mostly be critical under specific alerting contexts that are not met in our baseline conditions, or not at a rate sufficiently high to alter total time awake. Next, in the above optogenetic study, and upon HCRT infusion in LC *in vivo*^[@CR20]^, NA^LC^ cell activation and state transition may not only be caused by released HCRT binding HCRTR1 on NA cells, but also HCRTR1 on synaptic terminals of a third LC cell type, e.g. glutamatergic neurons^[@CR73]^, thus enhancing glutamate release, NA cell firing, and thereby the probability of awakening. The latter mechanism would be preserved in CKO mice.

While CKO mice' waking time was not changed, its ECoG spectral distribution was. Baseline waking was enriched in δ (1.25--2.75 Hz) frequencies, and upon EW and CC, in δ and inter-δ/θ frequencies, both of which reflect homeostatic sleep pressure in rodents and humans. Waking δ activity moreover correlates with declining cognitive performance during prolonged waking, and elevation of δ, θ/α, and β power, while γ power fades, correlate with subjective sleepiness^[@CR55],[@CR74]--[@CR81]^. Thus an increase in slow (infra-θ) oscillations in CKO mice suggests a less alert waking state, which appears to affect waking globally, as active waking (TDW) is also excessively δ-rich. Mechanistically, waking δ activity may stem from localized SWS network activity occurring in the brain of a globally awake, but sleepy, animal^[@CR82]^.

Increased waking β and slow-γ activity {#Sec14}
--------------------------------------

In times of enhanced arousal, such as during EW and nestbuilding, CKO mice display enriched β, or β and slow-γ (\~15--45 Hz) power. Dopamine-depleted rodents also exhibit increased β/slow-γ activity while performing particular tasks^[@CR62],[@CR83]^. Whether alterations in dopaminergic transmission are also present in our mice, potentially resulting from diminished dopamine release from NA^LC^ cells^[@CR69]^, or from downregulation of a HCRT-NA^LC^-DA^VTA^ circuit, deserves further investigation. Its association with impaired motor control also merits further investigation. Pathological β oscillations are present in Parkinson's patients, as an 'antikinetic β band' correlated with movement disorder^[@CR61]^. *Hcrt*-KO mice also show enhanced β/slow-γ activity in the minute that precedes cataplexy, which is characterized by indices of both electrocortical and behavioral arousal, with vigorous activity, including nestbuilding^[@CR84]^. Dysregulated motor events can also directly precede cataplexy, supporting the hypothesis that our mice' β/slow-γ-enriched wake is related to PD' antikinetic rhythm. Furthermore, the increase of β/slow-γ frequencies associated with diminished θ we observe in periods of intense arousal aligns with observations in rats, in which LC activation caused a suppression of β/slow-γ (12--40 Hz) frequencies, while enhancing θ oscillations^[@CR85]^. LC activation was suggested to mediate this effect by repressing inhibitory hippocampal interneurons, thus enhancing conditions for synaptic potentiation and learning.

Diminished induction of θ and fast-γ frequencies in threat-associated wakefulness {#Sec15}
---------------------------------------------------------------------------------

In stressful conditions, as experienced by the mice during sleep deprivation and following CC, CKO mice had a reduced ability to mount a normal arousal response, consisting of a sharp θ spectral peak associated with a fast-γ power surge. This observation aligns with numerous prior findings. Various types of stress are associated with activation of HCRT neurons^[@CR8]^, and we previously showed that HCRT is essential to stabilize θ-- and fast-γ (θ/fast-γ) --enriched wakefulness in some environments^[@CR53]^. The emergence of a narrow-bandwidth θ rhythm at the transition from quiet-to-active waking may involve a process enhancing or stabilizing θ oscillatory synchrony in hippocampal or neocortical networks, and NA^LC^ activation indeed enhances θ power and resets θ synchronization in hippocampus and neocortex^[@CR86]--[@CR88]^. It was recently proposed that a temporal relationship between LC neuron spiking, NA release, and the phase of θ and γ oscillations exists, and participates in the mechanisms through which the LC resets network activity and mediates attentional shift in response to salient stimuli, and by which it may also coordinate off-line events of importance for learning and memory^[@CR89]^. Our mouse model may add to this view the role of the input contributed by the HCRT-to-NA^LC^ pathway in modulating LC activity in distinct behavioral contexts. Our data are also consistent with *in vitro*^[@CR90]^, and *in vivo*^[@CR91]^ reports evidencing the role of HCRT in θ wave activity through action on the medial septum. Both NA^[@CR92]^ and HCRT^[@CR90]^ have excitatory activity on septal GABAergic parvalbumin-expressing (PV) neurons. These cells participate into septo-hippocampal GABAergic reciprocal circuits, that are thought to be critical to disinhibit and synchronize hippocampal principal cells, thus generating the θ--rhythm^[@CR93],[@CR94]^. In the hippocampus, HCRT was also reported to regulate θ--associated plasticity by a presynaptic mechanism involving NA synaptic terminals^[@CR95]^. Thus our findings reinforce the evidence linking HCRT, NA and hippocampal θ oscillations. Behavioral investigation of NA- and hippocampus-dependent forms of learning and memory in CKO mice are needed to shed light on the functional correlates of our observations.

Although we do not have θ-γ phase coupling data, a salient finding of our study is the consistent association between θ and fast-γ dynamics. The hippocampal networks that implicate the PV neurons mentioned above were suggested to play a role in coupling the θ rhythm with γ (35--85 Hz) waves^[@CR96]--[@CR98]^. Thus PV cells may contribute to the processes by which NA^LC^ activity supports phase-coupled rhythms^[@CR99]^, and their regulation by a HCRT input. In addition, NA is known to increase γ (30--60 Hz), and decrease δ activity when injected in the basal forebrain of rats, an effect thought to be mediated by a depolarizing activity on cholinergic neurons^[@CR100]^. Basal forebrain cholinergic cells project cortically and their role on stress-induced, HCRT-dependent arousal and the oscillatory changes we observe in our mice merits further investigation.

Inverted θ and fast-γ responses in nesting-associated vs. stress-associated wakefulness {#Sec16}
---------------------------------------------------------------------------------------

The ECoG exhibits a sharp spectral peak at θ frequencies (8--10 Hz), and a concomitant rise in fast-γ power when mice engage in intensive voluntary behaviors, both in threat-avoiding, or reward-seeking conditions. We exposed CKO and CTR mice to both types of contexts. Gentle handling during EW, and CC both induce a threat-avoiding-like response^[@CR63]^, while nest material induces vigorous nestbuilding, and is rewarding^[@CR59]^. CKO mice exhibited abnormal electrocortical responses in both types of conditions, albeit in opposite directions. They showed lower θ and fast-γ activity than controls in enforced and CC-induced waking, but θ and fast-γ power was higher than controls in late-night nestbuilding-associated waking preceding sleep. What could explain these opposite responses?

While arousal induced by both aversive and appetitive stimuli engage high θ and fast-γ oscillatory activity, they likely use distinct neurocircuits. Both are however expected to be modulated by HCRTR1 signaling^[@CR8]^. Our prior work has demonstrated that θ/fast-γ-enriched waking is differently regulated when waking is spontaneous, or enforced, and differently affected by HCRT deficiency^[@CR53]^. Considering the high complexity of HCRTR1 neurotransmission at both the circuit and cellular levels, a multitude of factors may contribute to context-dependent modulation of θ and fast-γ oscillations. As a working hypothesis, we focus on fear- (amygdala), and reward- (VTA) related structures, which receive both direct projections from HCRT and NA cell groups^[@CR101]--[@CR103]^.

A serial HCRT-NA^LC^-lateral amygdala (LA) circuit in which intra-LC HCRTR1 signaling features a key role was recently shown to be critical for formation, maintenance, and extinction of fear memory^[@CR104]--[@CR106]^. Blocking LC HCRTR1 activity reduced, while upregulating HCRT signaling within the LC enhanced, freezing behavior, a readout of fear memory. Furthermore, inhibition of HCRTR1 signaling within the amygdala facilitated fear memory extinction^[@CR107]^.

Therefore, loss of HCRTR1 at the level of NA^LC^ cell bodies, and/or at synaptic terminals in the amygdala, may contribute in blunting the fear response of CKO mice. It may be relevant to note in this context that reduced amygdalar activity during aversive conditioning was reported in human narcolepsy^[@CR108]^. CKO mice' deficient θ and fast-γ oscillatory response upon EW and CC may indicate a weakened alerting response to threat. This is consistent with the observation that CKO mice' waking ECoG spectra during EW and after CC are markedly enriched in frequencies associated with diminished alertness and sleepiness (δ, inter-δ/θ and β/slow-γ), compared to CTRs. A reduced fear response may contribute, conversely, to CKO mice' enhanced behavioral activation during the self-motivated activities mice spontaneously engage in nocturnally, or when nest material is provided, causing the increased waking time, and θ/fast-γ oscillatory response they express in late-night phase, which is rich in pre-sleep nestbuilding activity. Assessment of CKO mice' fear response will however require more elaborate behavioral and physiological measures of fear.

Tests for impulsivity and risk-taking behavior may furthermore complement assessment of CKO mice fear response. Increased impulsivity, and patterns of disadvantageous decision making were reported in narcolepsy^[@CR109],[@CR110]^. These traits were hypothesized to result from emotional blunting associated with HCRT deficiency. Thus, although increased sleepiness is a cardinal symptom of narcolepsy, other symptoms such as increased impulsivity, or binge-eating behavior, might suggest forms of hyperarousal^[@CR110],[@CR111]^. An increased incidence of attention deficit hyperactivity disorder (ADHD) symptomatology is reported in narcolepsy^[@CR112]^.

At the cellular, mechanistic level, the bidirectional θ/fast-γ response of our CKO mice may involve multiple NA cell signaling pathways. Again we focus on one example. In addition to promoting NA release from axonal terminals in target tissues, HCRT is also reported to trigger and potentiate NA secretion non-synaptically, from the somata and dendrites of NA^LC^ cells^[@CR113],[@CR114]^, in a process that is HCRTR1-, and NMDA receptor-dependent^[@CR113]^. Therefore HCRTR1 may not only modulate NA release in targets, but also in the LC. Because binding of locally secreted NA to NA^LC^ cell autoreceptors represses NA^LC^ activity^[@CR115]^, somatodendritic secretion provides a negative feedback regulatory pathway by which HCRTR1 may inhibit LC activity. NA somatodendritic secretion was indeed suggested as a potential therapeutic target to depress the NA^LC^ hyperactivity that results from opioid withdrawal^[@CR113],[@CR116]^. Because somatodendritic NA secretion has distinct properties compared to classical synaptic transmission, including delayed kinetics and a tight dependence on the frequency of the incoming stimulation^[@CR117]^, it may be favored over the latter in some behavioral contexts, possibly contributing to the enhanced behavioral activation and θ/fast-γ response of CKO mice in nocturnal nesting conditions.

Chronic loss of HCRT-to-NA signaling does not cause overt cataplexy {#Sec17}
-------------------------------------------------------------------

HCRT deficiency is known to cause the life-long disease narcolepsy with cataplexy. Ample evidence in canine models implicated the NA system in the control of cataplexy, leading to the NA hypoactivity hypothesis of cataplexy^[@CR118]^. In narcoleptic dogs, NA cells cease firing at the onset of cataplexy episodes and resume spiking at cataplexy offset^[@CR119]^, suggesting NA^LC^ activity is critical to couple arousal with muscle tone. Burgess and Peever^[@CR120]^ suggested that cataplexy is caused by loss of HCRT control of the NA system, which is dispensable for consciousness, but needed for its association with muscle tone. Although a comprehensive video-based behavioral assessment of CKO mice is yet to be performed, these animals did not demonstrate obvious electrocortical, or behavioral evidence of cataplexy^[@CR84]^, in concordance with more recent studies^[@CR32],[@CR121]^.

HCRT-to-NA signaling deficiency affects the spectral quality of SWS {#Sec18}
-------------------------------------------------------------------

We found that SWS following stressful wake is selectively deficient in slow-δ (δ1) power in CKO mice. This is reminiscent of our observation of a similar δ1 deficit in the SWS of *Hcrt*^*ko*/*ko*^ mice following spontaneous waking. The latter was associated with a profound deficit of *Hcrt*^*ko*/*ko*^ mice in expressing θ and fast-γ activity during baseline waking, due to a profoundly reduced ability to sustain spontaneously electrocortical arousal (the TDW state), as reflected by a much lower average TDW bout duration compared to controls^[@CR53]^. Here, we show that CKO mice express a waking state globally reduced in θ/fast-γ activity under stressful conditions, although TDW episode duration is essentially normal (Fig. [S3](#MOESM1){ref-type="media"}). Thus a deficit in δ1 activity is selectively observed in SWS subsequent to θ/fast-γ-power-impoverished waking. We have shown that time spent in θ/fast-γ-rich/TDW state was the key driver of the sleep homeostatic response, since its proxy SWS δ power was seen to correlate with prior time spent in TDW, rather than in all waking^[@CR53]^.

A dependency of SWS δ1 on prior waking θ/fast-γ activity is strengthened by our observation that CKO mice' SWS after nesting-associated wake, which, inversely to EW and CC waking, exhibit enhanced θ/fast-γ activity relative to controls, shows normal δ1 power. Our findings are also in line with the report that recovery SWS of rats that were depleted from cortical NA show a similar selective δ1 deficit^[@CR66]^. Moreover, cortical expression of a set of synaptic activity-related genes was found to be diminished in these rats during EW^[@CR66]^, as we also found to be the case in *Hcrt*^*ko*/*ko*^ mice in baseline dark phase^[@CR53]^.

Altogether these studies suggest that the δ1 component of SWS activity has a privileged homeostatic link with, and dependency upon, θ/fast-γ oscillatory activity in prior waking. θ/fast-γ-dependent potentiating events, or other plasticity changes within cortical circuits which get facilitated by HCRTR1-mediated noradrenergic signaling during waking, may be causally linked to δ1 oscillations in subsequent SWS^[@CR122]^. Our study suggests that HCRTR1-dependent NA signaling contributes to the homeostatic weight of waking, in particular as it is reflected in δ1 power in ensuing SWS. This hypothetically predicts that SWS δ1 oscillations mediate a specific, yet unknown, function in SWS-associated recovery processes.

The relation between the slow-δ (δ1) component of SWS and the cortical slow (\<1 Hz) oscillation of alternating UP and DOWN states in cortical neurons^[@CR123]^, is unclear. Whereas the slow oscillation was originally identified through intracellular recordings, δ1 is a Fourier--derived rhythmic component of the ECoG. Two features of δ1 nevertheless suggest that δ1 and the slow (\<1 Hz) oscillation are distinct: (i) the latter is reported to peak at \~0.3 Hz, whereas our δ1 rhythm is distinctly faster (0.75--2.25 Hz); (ii) while we clearly document the wake/sleep-dependent homeostatic regulation of δ1, whether the slow oscillation is under homeostatic regulation is controversial. Both early and recent EEG studies in humans have suggested that the oscillatory component below 1 Hz is unresponding to sleep deprivation^[@CR124],[@CR125]^, strengthening the hypothesis that the two rhythms have different origins. This important question warrants further studies.

PS state consolidation {#Sec19}
----------------------

Lastly, while CKO mice' episode number, duration, and total time spent in waking or in SWS were normal in the conditions we tested, the mice exhibited a modest but significant increase in PS stability, resulting in a shift towards longer PS bouts. Both HCRT and NA are known to have PS-antagonizing activities. Inhibiting NA signaling enhances, while increasing NA represses, PS^[@CR126]^. Narcoleptic patients show an increased propensity to express the PS state^[@CR127]^, and the same is true for Hcrt deficient mice in some conditions^[@CR53],[@CR84],[@CR128]^. The direct administration of HCRT-1 peptide into the LC of rats was shown to cause a decrease in both PS episode number and duration^[@CR20]^. In our mice, chronic NA cell HCRTR1 deficiency appeared to increase PS maintenance, but PS initiation was unchanged.

Conclusions {#Sec20}
===========

Brain processes that alter the generation or the stability of θ and fast-γ waves appear particularly active in presence of ethologically-relevant stimuli, of either repulsive or attractive valence, of importance for survival. These dynamics can result from neuromodulation of circuits by wake-promoting molecules, such as NA and HCRT, and their receptors. Many of the mechanisms, both at cell and circuit level through which these molecules act remain elusive. While HCRT is essential for state stability^[@CR129]^, including stability of the θ/fast-γ-enriched TDW state^[@CR53]^, we suggest that the HCRT-to-NA circuit is a context-dependent modulator of the different spectral domains in which brain networks can engage, and that differentially assist and organize brain operations in wake, and their processing in sleep.

The understanding of how HCRT neurotransmission affects noradrenergic function has clinical relevance beyond implications for narcolepsy and cataplexy, as HCRTR antagonists are being developed as novel therapeutic agents not only for insomnia, but also in several neuropsychiatric disorders, such as anxiety, depression, and various forms of hyperarousal, including cocaine-withdrawal-, and post-traumatic-stress-related hyperarousal^[@CR130]^. Furthermore, HCRTR1 ability to modulate LC neuronal activity is providing a novel therapeutically relevant tool in several neurodegenerative disorders in which LC neuronal damage appears to be an early event^[@CR131]^. Many remaining challenges exist for HCRTR antagonists' use in clinics, in particular because of the pleiotropy of HCRT functions, affecting not only arousal, but also e.g. food uptake, motivation and mood. The bidirectional effects of *Hcrtr1* disruption in the NA system we report warrant further studies also for these reasons. Thus our mouse model, and others that similarly inactivate a specific neuromodulator receptor in selective cell populations, will contribute in dissecting the mechanisms by which these molecules shape brain states and behavior.

Methods {#Sec21}
=======

*Hcrtr1* gene engineering: creation of a CRE-dependent conditional KO (*Hcrtr1*^*tm1*.*1Ava*^) allele {#Sec22}
-----------------------------------------------------------------------------------------------------

### Targeting strategy {#Sec23}

We inserted a 5′loxP site in the 5′ untranslated region of the first coding exon (exon 3 according to^[@CR132]^) of *Hcrtr1*, 27 bp downstream of exon 3's splice acceptor site, and 12 bp upstream of the initiation codon. The 3′ loxP site was inserted midway in intron 4 as a *loxP*-*Kozak*-*Gfp*-*rabbit globin p*(*A*)-*FRT*-*Neo*-*FRT* cassette. The inter-loxP distance is 1.1 kb.

### Mutagenesis {#Sec24}

The targeting vector for homologous recombination (Fig. [1a](#Fig1){ref-type="fig"}) was built using plasmid artificial chromosome (PAC) RP23-12J1 (BACPAC Resources Center, Oakland, CA, USA) a PAC from a *C57BL6*/*J* genomic DNA library containing *Hcrtr1*. Homologous arms spanning in total 10.0 kb were synthesized by PCR amplification of PAC RP23-12J1 using LA Taq (Takara), and Accuprime High-Fidelity (invitrogen) DNA polymerases. The targeting vector was linearized and electroporated in IC1, an embryonic stem (ES) cell line derived from *C57BL*/*6NTac* mice (ingenious targeting laboratory, Ronkonkoma, NY, USA). Single colonies were screened by Southern blot analysis using probes external to the targeting vector in both 5′ and 3′, and a *Gfp* internal probe. Two ES cell clones having undergone correct recombination events were identified and injected into *BALB*/*cAnNHEW* blastocysts. Resulting chimeras were mated to *Tg*(*ACTFLPe*)*9205Dym* transgenic mice^[@CR133]^ to excise the FRT-neo-FRT cassette. The neo-excised final conditional KO allele, *Hcrtr1*^*tm1*.*1Ava*^ (MGI: 5637400), is referred hereafter as *Hcrtr1*^*flox*^ (<http://www.informatics.jax.org/allele/MGI:5637400>).

Generation of noradrenergic cell-specific *Hcrtr1*-KO (*Hcrtr1*^*Dbh*-*CKO*^) mice, and evidence of tissue-specific, Cre-dependent *Hcrtr1*^*flox*^ allele recombination and genomic deletion {#Sec25}
---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

To inactivate *Hcrtr1* in NA cells, transgenic *Tg*(*Dbh*-*icre*)^*1Gsc*^ mice, which carry a PAC transgene with *Dopamine*-*β*-*hydroxylase* gene (*Dbh*) sequences driving *Cre*^[@CR36]^, were mated with *Hcrtr1*^*flox*^ mice. Two PCR assays flanking the loxP sites of *Hcrtr1*^*flox*^ were designed to amplify a diagnostic fragment of the recombined allele, and a 1.1 kb larger fragment (inter-loxP distance) from the unrecombined allele. Genomic DNA was prepared from tissue punches made in brain slices containing the LC, or other brain areas. Genomic DNA from the LC area of *Hcrtr1*^*Dbh*-*CKO*^ mice amplified the diagnostic recombined fragments, but not from the LC of *Hcrtr1*^*Dbh*-*CTR*^ littermates, neither from neocortex, or ear tissue of either CKO or CTR mice. CKO mice' PCR products were gel purified and sequenced in both orientations, confirming accurate recombination at the nucleotide level in 2 *Hcrtr1*^*Dbh*-*CKO*^ animals.

Generation of *Hcrtr1* KO/GFP-reporter (*Hcrtr1*^*tm1*.*2Ava*^) mice {#Sec26}
--------------------------------------------------------------------

*Hcrtr1*^*flox*/*flox*^ mice were mated to *Tg*(*EIIa*-*cre*)*C5379Lmgd* transgenic mice^[@CR49]^, which express *Cre* at embryonic preimplantation stages. Offspring that stably transmitted the recombined (*Hcrtr1*^*tm1*.*2Ava*^) allele were selected for further breeding, and *Tg*(*EIIa*-*cre*) was segregated out. Genomic DNA extracted from two animals was sequenced to confirm accurate CRE/loxP recombination at *Hcrtr1*. Resulting mice carry the recombined KO/GFP-reporter (*Hcrtr1*^*tm1*.*2Ava*^ MGI: 5637401, or *Hcrtr1*^*KO*-*Gfp*^) allele in all cells (<http://www.informatics.jax.org/allele/MGI:5637401>). Because the GFP coding sequence in this allele does not, unlike the HCRTR1 coding sequence that it replaces, carry a N-terminal signal peptide, it generates cytoplasmic GFP, which distributes through soma and neurites. Thus GFP expression reflects *Hcrtr1* promoter expression, but does not inform about HCRTR1 protein intracellular distribution.

Experimental mice {#Sec27}
-----------------

All mice derived from mating between *Hcrtr1*^*flox*/*flox*^ mice, with one of the two parents hemizygous for *Tg*(*Dbh*-*Cre*). These crosses generate two offspring groups: *Hcrtr1*^*flox*/*flox*^; *Tg*(*Dbh*-*Cre*)^+^ mice, in which NA cells express *Cre* (*Hcrtr1*^*Dbh*-*CKO*^, or CKO mice), and *Hcrtr1*^*flox*/*flox*^ littermates, which do not express *Cre* (*Hcrtr1*^*Dbh*-*CTR*^, or CTR mice). All analyses relied on pair-wise phenotype comparison between these two groups. All mice share a *C57BL*/*6NTac X C57BL*/*6J* mixed genetic background. All ECoG data are derived from 10 to 13-week-old males (weight 27--31 g). Mice were individually housed with food and water *ad libitum* under an LD12:12 cycle (lights-on, i.e., *Zeitgeber* Time ZT0, at 08:00 AM). All experiments were performed in accordance with the Swiss federal law, and using protocols approved by the State of Vaud Veterinary Office.

ECoG/EMG, video and locomotor activity (LMA) recording {#Sec28}
------------------------------------------------------

Electrodes for differential fronto-parietal ECoG and EMG recording were implanted as described^[@CR134]^. Mice were allowed to habituate to the EEG-setup for a minimal of 10 days, before the recordings were started (Fig. [2](#Fig2){ref-type="fig"}). Hardware (EMBLA A-10) and software (Somnologica-3) were from Medcare Flaga (EMBLA, Thornton, USA). ECoG and EMG signals were amplified, filtered, analog-to-digital converted, and stored at 200 Hz. Behavioral states (wake \[W\], slow-wave-sleep \[SWS\], and paradoxical sleep \[PS\]) were scored visually in 4-second (4-s) epochs using published criteria^[@CR135]^. Theta-dominated-waking (TDW) epochs were identified among waking epochs using an ECoG-based algorithm as described^[@CR53]^. Behavioral monitoring was done using infrared video-cameras^[@CR84]^. Locomotor activity was assessed using top-mounted passive infrared motion detectors (Visonic Ltd, Tel Aviv, Israel), and analyzed at 1-min resolution using ClockLab software (ActiMetrics, IL, USA).

ECoG power spectral density (PSD) analysis {#Sec29}
------------------------------------------

The ECoG signal was subjected to discrete Fourier transform to yield power density spectra (0.75--90 Hz) in 4 s epochs (0.25 Hz frequency resolution; Hamming window function). For each behavioral state and mouse, a mean ECoG spectrum was obtained by averaging spectra of all artefact-free epochs of that state and flanked by same-state epochs^[@CR135]^. To account for individual differences in absolute ECoG power, power density is expressed as % of a baseline ECoG power reference ('% of BL total power'), which is calculated for each mouse across two days, all states, and summation of the 0.75--40 Hz frequency bins. This reference is weighted so the relative contribution of each state is identical for all mice^[@CR135]^. Reference values for *CKO* and *CTR* mice did not differ (CKO *vs*. CTR 1181 ± 127 uV^2^ *vs*. 1181 ± 120 uV^2^, t~14~ = 0.00105, *P* = 0.99). Power density values across 47.5--52.5 Hz were excluded due to the 50 Hz AC power line noise. Power density values across 71.25--77.25 Hz were also excluded due to artefacts of unknown origin present in some mice (EW: 6/16, 3CKO:3CTR; CC: 4/14, 1CKO:3CTR; Nest experiment: 4/10, 1CKO:3CTR). To rule out that some of the power spectral density changes observed in CKO relative to CTR mice are an effect of referencing power density values to the individual's mean 'total power' as described above, we also compared the spectral density profiles of the two genotypes using their absolute ECoG power values. This yielded significant spectral differences between CKO and CTRs in the same frequency bands as the ones obtained with the 'total power' reference. Greek symbols were used to define specific ECoG frequency ranges as follows: δ (1--4 Hz), inter-δ/θ (4--7 Hz), θ (7.5--11.5 Hz), β (15--30 Hz) slow-γ (γ-1: 32--45 Hz), and fast-γ (γ-2: 55--80 Hz). In Fig. [3e](#Fig3){ref-type="fig"} inset and Supplementary Table [S2](#MOESM1){ref-type="media"}, the dominant frequency of θ oscillations (θ peak frequency, TPF) was evaluated in each mouse as the frequency at which ECoG power density in the average waking spectral profile was highest in the 5--10 Hz range^[@CR136]^.

Temporal dynamics of integral PSD in specific frequency bands {#Sec30}
-------------------------------------------------------------

The dynamics of ECoG activity within specific frequency ranges in waking across various contexts and periods of time were analyzed by dividing the period concerned into a same number of time intervals ('percentiles') for all animals, each percentile contributing an equal number of 4 s epochs scored as waking. The number of time intervals, and thus of data-points, was adjusted according to the prevalence of wakefulness (e.g., 6 in baseline light phase, 12 in dark phase, 8 during the 6-h EW, and 4 in recovery light phase, for Fig. [3d](#Fig3){ref-type="fig"}). For each time interval, the mid-points were averaged among animals of a given genotype, and mapped back onto real time. Because time-spent-awake (e.g. from cage change to SWS-onset) may differ between genotypes, data-points of each genotype do not necessarily coincide in time (x-value). ECoG power density in each frequency band was expressed relative to its average value in baseline wake (ZT0--24; Figs [5g](#Fig5){ref-type="fig"} and [7a](#Fig7){ref-type="fig"}), or relative to the 'baseline total power reference' described above (Fig. [3d](#Fig3){ref-type="fig"}). Genotype differences in ECoG power dynamics were statistically evaluated according to the percentile sequence, i.e. CKO and CTR mice' ECoG power values were compared in each successive time percentile.

3D (ECoG Power:Frequency:Time) heatmap analysis of wakefulness {#Sec31}
--------------------------------------------------------------

To analyze the time dynamics of the entire ECoG spectrum (0.75--90 Hz) in waking, power density in each 0.25 Hz frequency bin was first expressed relative to its average level in baseline light phase waking across the ZT8--12 time interval, then averaged across each time interval, and individual of each genotype. Results are visualized as a 3D 'heatmap', with larger changes in power density appearing as warmer colors. It is important to note that, in heatmaps, (as in all analyses depicting *ratios* between ECoG power values), the frequencies at which the ECoG power value peaks (warm-colored areas) do not represent the precise frequencies of the brain's actual most powerful oscillations, but rather the frequencies at which power densities maximally differ with reference baseline values. These frequencies are slightly right-shifted (higher), relative to the frequencies of the actual brain oscillatory rhythms that dynamically respond to the environmental contingencies under analysis. This principle is illustrated in Fig. [S4](#MOESM1){ref-type="media"}.

Behavioral exposure {#Sec32}
-------------------

Cohorts of CKO and CTR (n = 9:7, CKO:CTR) littermate mice were sequentially exposed to four experimental contexts, as their ECoG/EMG data were acquired: (i) baseline (undisturbed) conditions, (ii) EW, (iii) nestbuilding, (iv) transfer to fresh cage. Only uninterrupted high-quality recordings were considered for analysis. Hence, (i--ii): n = 9:7; (iii): n = 5:5; (iv): n = 8:6 (CKO:CTR) animals were analyzed.

### Spontaneous and enforced wakefulness {#Sec33}

Mice were recorded for 3 continuous days, consisting of two undisturbed (baseline) days (BL1 + BL2), a 6-h period of 'gentle handling'^[@CR134]^ initiated at light onset (ZT0) of the 3^rd^ day to maintain animals awake, and a 18-h 'recovery' (undisturbed) period. To avoid sleep during EW, tissue paper was introduced in the cage at ZT2 and ZT5, and midway through EW (ZT3), mice were transferred into a fresh cage.

### Nest material interaction {#Sec34}

Following the day of the EW, mice were left undisturbed for ≥2 days. At dark onset (ZT12) of day 6, a square of highly packed shreddable cotton (Nestlet^TM^, Ancare, Bellmore, NY, Ref. Nr. 14010) was introduced in the cage. Mice were then left undisturbed through the night until light onset and assessment of nest morphology. All nests (CKO n = 5; CTR n = 5) were found to score at least 3 according to Gaskill *et al*.'s^[@CR59]^ nestbuilding scale.

### Cage change (CC) {#Sec35}

Following nest assessment, mice were left undisturbed for another ≥2 days. On ZT3 of day 9, mice were transferred from their homecage where the nest had been built to a fresh cage. Latency to SWS-onset was defined as the time until the first SWS episode lasting ≥2 min and interrupted by ≤3 epochs scored as wakefulness.

Immunofluorescence {#Sec36}
------------------

\~16-wk old mice were deeply anesthetized with sodium pentobarbital (100 mg/kg, i.p.), and transcardially perfused with 4% paraformaldehyde (pH 7.4). Brains were quickly removed, post-fixed in the same fixative for 2 h at 4 °C, then immersed successively in 15% (1 h) and 30% sucrose (o/n) at 4 °C, frozen and stored at −80 °C until use. Coronal sections (20-µm) were collected on SuperFrost-Plus glass slides, blocked in 2% BSA, 5% normal donkey serum, 0.3% TritonX-100 in TBS (pH 7.5) for 30 min at r.t., and antibodies were applied in 1% BSA, 0.2% TritonX-100 in TBS, and incubated o/n at 4 °C. When double staining involved the HCRTR1 antibody, an additional 'antigen-retrieval' step in Sodium Citrate buffer (pH 6.0) buffer at 55^o^ C for 7 min was applied before blocking and primary antibody incubation. Antibodies were: anti-tyrosine hydroxylase (TH) from mouse (Incstar, Cat\#22941; 1:5000), anti-green fluorescent protein (GFP) from chicken (Aves Labs, Cat\#1020; 1:500), anti-CRE from rabbit (Novagen, Cat\#69050-3; 1:500), and anti-HCRTR1 from rabbit (Origene Cat\#TA328918; 1:100--1:500). This HCRTR1 antibody was raised against a 15-aa peptide from the third intracellular loop of rat HCRTR1, i.e. a region downstream of the 126-aa deletion mediated by CRE/loxP recombination of the floxed *Hcrtr1* allele Secondary antibodies were donkey IgGs coupled to Alexa-594, or -488 fluorophores, and were incubated at a 1:500 dilution for 1 h at r.t.

Confocal microscopy {#Sec37}
-------------------

Images were acquired on an inverted Zeiss LSM710 confocal laser-scanning microscope (405, 488, and 561 nm lasers) using a 40x oil objective (EC plan-Neofluar 40x/1.30 Oil DIC M 27). For each animal used for cell quantification, sections collected at 4 Bregma levels within the LC (representing approx. 1 out of 9 sections) were used (−5.34, −5.40, −5.52, −5.68 mm from Bregma^[@CR137]^. Confocal images covering the entire LC TH^+^ cell field were acquired at 8-bit image depth and a frame of 1,024 X 1,024 pixels, and tiled together using ZEN software. A square frame centered within the LC field was drawn (1,024 X 1,024 pixels at 40X, as shown in Fig. [1b--f](#Fig1){ref-type="fig"}), and immunoreactive cell counts were evaluated within that frame using ImageJ software. Images were minimally processed in the same manner for the two genotypes.

Statistics {#Sec38}
----------

Data were assessed for normal distribution using Shapiro-Wilk normality test, and nonparametric Mann-Whitney statistics were used if the test failed. Otherwise, timecourse and ECoG power spectral density analyses were assessed first by two-way ANOVA for factors 'genotype' and 'time-of-day', or 'genotype' and 'frequency bin', and their interaction. Only if a significant effect was found for the factor genotype, or/and the two-factor interaction, were genotypes contrasted by independent *t*-tests. Within-group effects, such as response to EW or nest material, were assessed using paired two-tailed Student's *t*-tests. Significance threshold was set at *p* \< 0.05. The results are shown as mean ± SEM. Data processing was performed using TMT Pascal Multi-Target5 software (Framework Computers, Inc., Brighton, MA, USA), and statistically assessed using SPSS V23 (IBM SPSS Statistics, Armonk, NY, USA), or SAS V9.2 (SAS Institute Software Inc., Cary, NC, USA). Figures were prepared using SigmaPlot V12.5 (Systat Software Inc., Chicago, IL, USA), and Adobe Illustrator CC 2015 (Adobe Systems).
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